In response to a U.S. Food and Drug Administration press release today announcing warning letters and Import Alert for ... (Business Standard India)
Ranbaxy is very disappointed in the action FDA has taken today. The company has responded to each concern FDA has raised during the past two years and had thought that progress was being made.

US FDA releases Novacea's prostate cancer drug clinical hold (PharmaBiz)
Novacea, Inc reported that it has received notice from the United States Food and Drug Administration (FDA) that the agency has released the clinical hold on the Asentar Investigational New Drug (IND) application.

Automated External Defibrillators - FDA Classifies As A Class I Action An Urgent Medical Device Correction By ... (Medical News Today)
Physio-Control, Inc., a wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT) announced the FDA has classified as a Class I action the company's recently initiated and completed voluntary urgent medical device recall of 249 fully automatic LIFEPAK CR Plus automated external defibrillators (AEDs).